For research use only. Not for therapeutic Use.
LZWL02003 is an anti-neuroinflammatory agent. LZWL02003 has protective effect on MPP+-induced neuronal damage, and reduces the expression of ROS. LZWL02003 improves cognition, memory, learning, and athletic ability in a Rotenone (HY-B1756)-induced PD rat model. LZWL02003 can be used for research of neurodegenerative disease[1].
| Catalog Number | I040782 |
| CAS Number | 1371564-45-2 |
| Synonyms | 2-hydroxy-N-[2-(1H-indol-3-yl)ethyl]-4-methylbenzamide |
| Molecular Formula | C18H18N2O2 |
| Purity | ≥95% |
| InChI | InChI=1S/C18H18N2O2/c1-12-6-7-15(17(21)10-12)18(22)19-9-8-13-11-20-16-5-3-2-4-14(13)16/h2-7,10-11,20-21H,8-9H2,1H3,(H,19,22) |
| InChIKey | IIXQVHOWQHXBKW-UHFFFAOYSA-N |
| SMILES | CC1=CC(=C(C=C1)C(=O)NCCC2=CNC3=CC=CC=C32)O |
| Reference | [1]. Li X, et al. Exploring the Therapeutic Effects of Multifunctional N-Salicylic Acid Tryptamine Derivative against Parkinson’s Disease. ACS Omega. 2023 Jul 28;8(31):28910-28923. |
